Alkem Laboratories invested ~₹1,100 Cr into its wholly-owned subsidiary, Alkem Medtech, via rights shares. This capital will fund Medtech's strategic acquisition of a 51-55% stake in Occlutech Holding AG, significantly expanding Alkem's footprint in the medical device segment.